The Latest Breaking News from AstraZeneca

Wall Street Journal

The U.S. Food and Drug Administration (FDA) has approved Spectrum Pharmaceuticals’ (NASDAQ:SPPI) lead asset ROLVEDON (eflapegrastim-xnst) injection to decrease the incidence of infection, as manifested by febrile neutropenia. Spectrum Pharmaceuticals shares traded as high as 3.17 percent, in a range of $1.21 to $1.30 on day volume of 6.8 million…

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Pfizer’s (NYSE:PFE) lead drug GBS6 or PF-06760805 for the prevention of invasive GBS disease due to the vaccine serotypes in newborns and young infants by active immunization of their mothers during pregnancy. Pfizer shares traded in a…

The drug reduces the risk of death by 20% compared with chemotherapy alone

Regulators in Australia and the United States last week approved Omicron-specific boosters, following approval in the United Kingdom in mid-August.

A jump in the number of deaths among children in Europe could be caused by numerous factors, experts said, but vaccines are not to blame.

The company first developed the drug as a treatment for type-2 diabetes 

Upgrades

The chief executive officer believes most of the vaccinated population now has a "foundation immunity against severe disease"

Chief executive officer Pascal Soriot said he believes most of the vaccinated population has a ‘foundation immunity against severe disease’.

Brave schoolboy Max Johnson said the Government should offer vital protection to hundreds of thousands of immuno-compromised people who, like him, could risk being killed by Covid-19